Статья

New approach of genetic characterization of group A rotaviruses by the nanopore sequencing method

E. Faizuloev, R. Mintaev, O. Petrusha, A. Marova, D. Smirnova, Y. Ammour, E. Meskina, O. Sergeev, S. Zhavoronok, A. Karaulov, O. Svitich, V. Zverev,
2021

Nanopore sequencing of virus genomes represented by segmented RNA (e.g. rotaviruses) requires the development of specific approaches. Due to the massive use of rotavirus vaccines, the relevance of monitoring the genetic diversity of circulating strains of group A rotaviruses (RVA) increased. The WHO recommended method of multiplex type-specific PCR does not allow genotyping of all clinically significant strains of RVA and identifying inter-strain differences within the genotype. We have described a new principle of amplification of RVA gene segments using six primers for reverse transcription and one universal primer for PCR for nanopore sequencing. The amplification of RVA genome was tested on clinical samples and three phylogenetically distant laboratory RVA strains, Wa (G1P[8]), DS-1 (G2P[4]) and 568 (G3P[3]). The developed protocol of sample preparation and nanopore sequencing allowed obtaining full-length sequences for gene segments of RVA, including the diagnostically significant segments 9 (VP7), 4 (VP4) and 6 (VP6) with high accuracy and coverage. The accuracy of sequencing of the rotavirus genome exceeded 99.5 %, and the genome coverage varied for different strains from 59.0 to 99.6 % (on average 86 %). The developed approach of nanopore sequencing of RVA genome could be a prospective tool for epidemiological studies and surveillance of rotavirus infection.

Цитирование

Похожие публикации

Документы

Источник

Версии

  • 1. Version of Record от 2021-06-01

Метаданные

Об авторах
  • E. Faizuloev
    I. I. Mechnikov Research Institute for Vaccines and Sera RAMS
  • R. Mintaev
    I. I. Mechnikov Research Institute for Vaccines and Sera RAMS, Centre for Strategic Planning and Management of Biomedical Health Risks
  • O. Petrusha
    I. I. Mechnikov Research Institute for Vaccines and Sera RAMS
  • A. Marova
    I. I. Mechnikov Research Institute for Vaccines and Sera RAMS
  • D. Smirnova
    I. I. Mechnikov Research Institute for Vaccines and Sera RAMS
  • Y. Ammour
    I. I. Mechnikov Research Institute for Vaccines and Sera RAMS
  • E. Meskina
    Moscow Regional Research and Clinical Institute
  • O. Sergeev
    Sechenov First Moscow State Medical University
  • S. Zhavoronok
    Belarusian State Medical University
  • A. Karaulov
    Sechenov First Moscow State Medical University
  • O. Svitich
    I. I. Mechnikov Research Institute for Vaccines and Sera RAMS, Sechenov First Moscow State Medical University
  • V. Zverev
    I. I. Mechnikov Research Institute for Vaccines and Sera RAMS, Sechenov First Moscow State Medical University
Название журнала
  • Journal of Virological Methods
Том
  • 292
Финансирующая организация
  • I.M. Sechenov First Moscow State Medical University
Номер гранта
  • undefined
Тип документа
  • journal article
Тип лицензии Creative Commons
  • CC BY
Правовой статус документа
  • Свободная лицензия
Источник
  • scopus